(NYSE: SNN) Smith & Nephew's forecast annual revenue growth rate of 5.26% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Smith & Nephew's revenue in 2025 is $5,810,000,134.On average, 2 Wall Street analysts forecast SNN's revenue for 2025 to be $5,385,711,375,361, with the lowest SNN revenue forecast at $5,377,930,527,752, and the highest SNN revenue forecast at $5,393,492,222,970. On average, 2 Wall Street analysts forecast SNN's revenue for 2026 to be $5,661,578,189,542, with the lowest SNN revenue forecast at $5,636,510,957,990, and the highest SNN revenue forecast at $5,686,645,421,094.
In 2027, SNN is forecast to generate $5,948,561,127,238 in revenue, with the lowest revenue forecast at $5,919,956,747,817 and the highest revenue forecast at $5,977,165,506,660.